Reach Us +44-1647-403003
David G Bostwick | OMICS International
ISSN: 2376-1318

Vitamins & Minerals
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

David G Bostwick

  Chief Executive Officer of AIBioTech and Bostwick Laboratories


Dr. David G. Bostwick is Chief Executive Officer of AIBioTech. Previously he was a professor of urology and pathology at the Mayo Clinic from 1991 until 1999. He also founded Bostwick Laboratories in 1999 and grew it to the leading urology and pathology practice in the United States and the United Kingdom.

An internationally renowned urologic pathologist with more than 30 years of experience and interest in prostate cancer, bladder cancer and urologic diseases, Dr. Bostwick is the most sought-after pathologist for second opinions in urologic pathology. He has presented more than 2000 lectures around the world, is past President of the International Society of Urological Pathology, and currently serves on the editorial board of ten medical journals. Dr. Bostwick has authored and edited 17 books, more than 30 book chapters and more than 400 professional papers. His book, Urologic Surgical Pathology (WB Saunders, 1997 and 2007) is the bestselling uropathology medical textbook. Other current best-sellers are his books American Cancer Society’s Complete Guide to Prostate Cancer (American Cancer Society, 2005) and Essentials of Pathology, 3rd Edition (Springer 2001, 2006, and 2011). His most quoted works include the first descriptions of prostatic intraepithelial neoplasia (1986) and atypical small acinar proliferation (1998).

Research Interest

prostate cancer, bladder cancer and urologic diseases


Global Speakers in the subject

Global Experts in the subject